A new HIV drug created by Israeli researchers has undergone the first human clinical trial.
At the end of the study, it was discovered that a drug called Gammora, created by Zion Medical, an Israeli biotechnology company, was able to remove 99 percent of cells infected with HIV in the human body.
According to the statement issued by the company and available on the site PR Newswire, Gammora was able to eliminate up to 90 percent of the virus during the first four weeks of the study.
Zion Medical developed the Gammora drug in collaboration with the Hebrew University of Jerusalem and Sirion Biotech in Germany.
The drug has the task of attacking and killing HIV-infected cells in the human body without causing damage to healthy cells.
READ ALSO: SIMPLY: Police invites, interrogates the wife of the murdered President of Credit Switch
In the study, the researchers randomly assigned nine participating patients from the Ronald Bata Memorial Hospital in Uganda to receive different doses of Gammory between 4 and 5 weeks in July and August of that year.
While the new anti-HIV drug is still in the first exploration stage, the results already gave hope that a cure for a terrifying virus is possible.
"Most patients showed a significant reduction in viral load to 90 percent from baseline in the first four weeks," says Dr Esmira Naftali, director of development at Zion Medical.
(We visited 86 times, 86 visits today)